Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cellular mechanisms in sepsis.
Jean-Baptiste E. Jean-Baptiste E. J Intensive Care Med. 2007 Mar-Apr;22(2):63-72. doi: 10.1177/0885066606297123. J Intensive Care Med. 2007. PMID: 17456726 Review.
Update About the Management of Low-Density Lipoprotein Cholesterol and Hypertriglyceridemia in Lower Extremity Peripheral Artery Disease Patients: Consensus of the French Society of Vascular Medicine and the French Society for Vascular and Endovascular Surgery.
Mahé G, Boge G, Bura-Rivière A, Chakfé N, Constans J, Goueffic Y, Lacroix P, Le Hello C, Pernod G, Perez-Martin A, Picquet J, Sprynger M; SFMV/SCVE Group. Mahé G, et al. Ann Vasc Surg. 2024 Mar;100:148-154. doi: 10.1016/j.avsg.2023.08.023. Epub 2023 Oct 6. Ann Vasc Surg. 2024. PMID: 37806655
Outcomes in the treatment of aberrant subclavian arteries using the hybrid approach.
Ben Ahmed S, Settembre N, Touma J, Brouat A, Favre JP, Jean Baptiste E, Chaufour X, Rosset E; AURC (Association Universitaire pour la Recherche en Chirurgie) collaborators. Ben Ahmed S, et al. Among authors: jean baptiste e. Interact Cardiovasc Thorac Surg. 2022 Oct 10;35(5):ivac230. doi: 10.1093/icvts/ivac230. Interact Cardiovasc Thorac Surg. 2022. PMID: 36179094 Free PMC article.
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Herman GA, O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Musser BJ, Davis JD, Turner KC, Mahmood A, Hooper AT, Hamilton JD, Parrino J, Subramaniam D, Baum A, Kyratsous CA, DiCioccio AT, Stahl N, Braunstein N, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. Herman GA, et al. Lancet Infect Dis. 2022 Oct;22(10):1444-1454. doi: 10.1016/S1473-3099(22)00416-9. Epub 2022 Jul 5. Lancet Infect Dis. 2022. PMID: 35803290 Free PMC article. Clinical Trial.
93 results